1-8 of 8
Kamil Kaplanov
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Final Results of CHRONOS19 Observational Study in Patients with Hematologic Disease and COVID-19 in Russia

Olga A. Gavrilina, Kristina A. Zakurdaeva, Anastasia N. Vasileva, Sergei Dubov, Vitaly S. Dubov, Vladimir I. Vorobyev, Lev S. Butaev, Lubov Gavrilova, Inessa Yu. Toropova, Marina O. Popova, Aleksander A. Siniaev, Kamil Kaplanov, Andrei Petrenko, Oksana Ochirova, Ekaterina Yu. Chelysheva, Yulia Sveshnikova, Vasily Shuvaev, Maria E. Grishunina, Julia A. Chabaeva, Alina Karpova, Alena Sukhareva, Dasha Baryshnikova, Tatiana V. Gaponova, Vera V. Troitskaya, Valery G. Savchenko
Journal: Blood
Blood (2021) 138 (Supplement 1): 4994.
https://doi.org/10.1182/blood-2021-152735
Published: 2021
Journal Articles

Quality of Life (QoL) and Clinical Outcomes in Patients with Relapsed/Refractory Multiple Myeloma (RRMM) Receiving Ixazomib-Lenalidomide-Dexamethasone (IRd) in a Real-World Setting

Tatyana Ionova, Elena Ado, Lyudmila Anchukova, Elena Babich, Dolgorzhap Dasheeva, Marina Demchenkova, Sergei Dubov, Tatiana Esenina, Lyudmila Ivanova, Kamil Kaplanov, Anna Kopylova, Yulia Kochkareva, Tatiana Kravchuk, Alexander Levanov, Olga Li, Tatiana Mitina, Tatiana Nikitina, Natalia Porfirieva, Elena Rimashevskaya, Oleg Rukavitsyn, Natalia Saraeva, Marina Savinova, Tatiana Shelekhova, Polina Simashova, Mariya Shirokova, Olga Vinogradova, Svetlana Volkova, Anna Zinkovskaya
Journal: Blood
Blood (2020) 136 (Supplement 1): 28–29.
https://doi.org/10.1182/blood-2020-134415
Published: 2020
Journal Articles

Outcomes Following Lenalidomide for Relapsed/Refractory Mantle Cell Lymphoma Patients at Risk of Bleeding Events Because of Multiple Comorbidities or Treatment: A Post-Hoc Subgroup Analysis of the SPRINT (MCL-002) Trial

Marek Trneny, Thierry Lamy, MDPhD, Jan Walewski, MD PhD, David Belada, MD PhD, Jiri Mayer, John A Radford, MB ChB, MRCP, MD FRCP, Wojciech Jurczak, MD PhD, Franck Morschhauser, Julia Alexeeva, MD, Simon A. Rule, MD, Boris V Afanasyev, Professor, Kamil Kaplanov, Antoine Thyss, MD, Alexej Kuzmin, MD, Sergey Voloshin, MD, Kazimierz Kuliczkowski, prof., Agnieszka Giza, MD, Noel Milpied, MD PhD, Caterina Stelitano, MD, Reinhard Marks, MD, Lorenz Trümper, MD, Tsvetan Biyukov, MD, Evelyn Barnett, Marie-Laure Casadebaig Bravo, MSc, Luca Arcaini, MD
Journal: Blood
Blood (2016) 128 (22): 2978.
https://doi.org/10.1182/blood.V128.22.2978.2978
Published: 2016
Journal Articles

Absence of High-Dose Consolidation Courses and Low Numbers of Allogeneic HSCTs Did Not Affect Overall Optimistic Results in B-Cell Precursor Ph-Negative Adult ALL Patients Treated By Non-Intensive but Non-Interruptive ALL-2009 Protocol: Data of the Russian ALL Study Group

Elena N. Parovichnikova, MD PhD, Vera V. Troitskaya, MD PhD, Andrey Sokolov, Galina Kliasova, Larisa A. Kuzmina, MD PhD, Sergey Kravchenko, MD PhD, Elena Gribanova, Segey Bondarenko, Olga Baranova, Tatyana Kaporskaya, Tatyana Ryltzova, Nina Minaeva, Tatiana Zinina, Olga Samoilova, Alfiya Nizamutdinova, Alexandra Klimovich, Elena Karyakina, Alexandra Eluferieva, Lyubov Gavrilova, MD, Tatyana Konstantinova, Natalya Vopilina, Kamil Kaplanov, Valery A. Lapin, Alexander Pristupa, Tatyana Tikunova, Zalina Akhmerzaeva, Tatiana N. Obukhova, PhD, Mikhail Rusinov, Sergei M Kulikov, PhD, Valeri G. Savchenko, MD PhD Prof.
Journal: Blood
Blood (2015) 126 (23): 2497.
https://doi.org/10.1182/blood.V126.23.2497.2497
Published: 2015
Journal Articles

The Results of the Russian Registry of Primary Immune Thrombocytopenia (ITP) in Adults

Igor Lisukov, MD, PhD, Alexey Maschan, Prof, Anastasia Shamardina, MD, Tatyana Chagorova, MD, Igor Davydkin, Prof., Tatyana Sycheva, MD, Tamara Zagoskina, MD, Elena Karyagina, MD, Galina Salogub, MD, Marina Savinova, MD, Tatyana Schelekhova, MD, Lidiya Kovaleva, Prof, Tatyana Schneider, MD, Anna Unzhekova, MD, Elena Kuznetsova, MD, Yuriy Schatochin, Prof, Maria Ivanova, MD, Elena Vinogradova, MD, Kamil Kaplanov, MD, Inna Markova, MD, Olimpiada Kanjukova, MD, Kudrat Abdulkadyrov, MD, Julia Sedlova, MD, Svetlana Osynikhina, MD, Nina Tsvetaeva, MD, Elena Volodicheva, MD, Aryslan Akhmadeev, MD, Michael A Maschan, MD PhD, Alexandr Kulagin, MD, PhD, Alexander Rumyantsev, Prof, Boris V Afanasyev, Professor
Journal: Blood
Blood (2015) 126 (23): 4642.
https://doi.org/10.1182/blood.V126.23.4642.4642
Published: 2015
Journal Articles

First Line BR in Chronic Lymphocytic Leukemia Patients: Interim Results of Russian Norma Trial

Elena Stadnik, Vladimir Strugov, Tatyana Silina, Natalya Ilyina, Yulia Virts, Renat Badaev, Galina Kuchma, Elena Volodicheva, Tatyana Sycheva, Tatyana Kaporskaya, Kamil Kaplanov, Natalya Glonina, Lyubov Anchukova, Tatyana Byalik, Olga Samoilova, Elena Kirillova, Sergey Shklyaev, Yulia Mirolubova, Tatyana Nikulina, Andrey Rumyantsev, Andrey Proydakov, Irina Lysenko, Vladimir Melnichenko, Natalya Esefeva, Tatyana Ksenzova, Igor Davidkin, Olga Vasilyeva, Oksana Ochirova, Oleg Rukavitsyn, Natalya Bulieva, Vera Zherebtsova, Andrey Gubkin, Yulia Bogdanova, Irina Chebykina, Elena Shukaeva, Andrey Zaritskey
Journal: Blood
Blood (2014) 124 (21): 3332.
https://doi.org/10.1182/blood.V124.21.3332.3332
Published: 2014
Journal Articles

Key Results of International Randomized Open-Label Clinical Study of BCD-020 (rituximab biosimilar candidate) in Patients with B-Cell Non-Hodgkin’s Lymphoma

Kamil Kaplanov, Andrey Zaritskiy, MD, Sergey Alexeev, MD, PhD, Elena Volodicheva, Alexander Loginov, MD, Rashida Orlova, MD, PhD, Victoria Dvornichenko, MD, PhD, Marina Kosinova, MD, Olga Serduk, Vladimir Milovanov, MD, Alexander Myasnikov, MD PhD, Shekar Patil, MD, Shekar Patil, MD, Bharath Rangarajan, MD, Senthil Jagannathan Rajappa, MD DM, Minish Jain, MD, Sharanabasappa Nirni, MD, PhD, Akhil Deka, M, Grigoriy B Rekhtman, Iryna Kryachok, Zvenyslava Maslyak, Ekaterina Chernyaeva, MD, Roman Ivanov, MD, PhD, Alexander Isaev, MD
Journal: Blood
Blood (2014) 124 (21): 5467.
https://doi.org/10.1182/blood.V124.21.5467.5467
Published: 2014
Journal Articles

Less Toxic Gemcitabine-Oxaliplatin Based Induction Regimen (R-GIDIOX) Prior to Autologous SCT Produces Outcomes Similar to High-Dose Cytarabine Containing Intensive Induction Regimen in Mantle Cell Lymphoma – a Follow up Report of the Multicenter Study

Vladimir I. Vorobyev, MD PhD, Sergei K. Kravchenko, MD PhD, Eduard G. Gemdzhian, PhD, Jana K. Mangasarova, MD PhD, Elena Baryakh, MDPhD, Alla M. Kovrigina, MD PhD Prof., Tatiana N. Obukhova, PhD, Kamil Kaplanov, Egor I. Dubrovin, MD, Ivan A Vorobjev, Prof., Natalya G. Turina, MD PhD, Valeri G. Savchenko, MD Prof.
Journal: Blood
Blood (2014) 124 (21): 1726.
https://doi.org/10.1182/blood.V124.21.1726.1726
Published: 2014